Rockefeller Capital Management
TNXP icon

Rockefeller Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Rockefeller Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.72K Hold
370
– – ﹤0.01% 4255
2026
Q1 		$5.09K Buy
370
+330
+825% +$5.08K ﹤0.01% 4235
2025
Q4 		$625 Buy
40
+14
+54% +$258 ﹤0.01% 4506
2025
Q3 		$628 Buy
+26
New +$965 ﹤0.01% 4241

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rockefeller Capital Management's TNXP Position: Q2 2026 in Review

Rockefeller Capital Management held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 370 shares worth $4.72K. The position accounts for ﹤0.01% of the portfolio, ranked #4255.

Rockefeller Capital Management first reported a position in TNXP in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.09K in Q1 2026. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Rockefeller Capital Management held 370 shares of Tonix Pharmaceuticals worth $4.72K as of Q2 2026.
  • Rockefeller Capital Management left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4255 holding.
  • Rockefeller Capital Management first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Tonix Pharmaceuticals position peaked at $5.09K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.